Serial 98529734
Live / Registered — Registered (as of 25 Aug 2026)
What this means for you
Registered since 25 Aug 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 25 Aug 2032: the §8 declaration of use).
Record
- Serial number
- 98529734
- Registration number
- 8413969
- Mark type
- Design / logo
- Filed
- 01 May 2024
- Published for opposition
- 15 Oct 2024
- Registered
- 25 Aug 2026
- Next maintenance filing
- §8 declaration of use, due by 25 Aug 2032 (grace period to 25 Feb 2033)
- Attorney of record
- Palak Mayani
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the prevention and treatment of bone, cardiovascular, central nervous system, dermatological, endocrine, hematological, hepatological, immunological, gastrointestinal, genitourinary, gynecological, metabolic, musculoskeletal, nephrological, neurological, oncological, ophthalmic, psychiatric, pulmonary, renal, respiratory, and urological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of RSV; Pharmaceutical preparations for the prevention and treatment of autoimmune diseases, asthma, cancer and tumors, chronic cough, diabetes, hypertension, insomnia, intestinal infections, skin disorders, and urinary incontinence; Pharmaceutical preparations, namely, anti-bacterials, antibiotics, anti-fungals, anti-infectives, anti-inflammatories, anti-parasitics, and antivirals; human vaccine preparations; Inhalers filled with pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and disorders.
Owner
- Merck Sharp & Dohme LLC, Rahway, NJ, US
- Merck Sharp & Dohme LLC, Rahway, NJ, US
- Merck Sharp & Dohme LLC, Rahway, NJ, US
Prosecution history
- 25 Aug 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 25 Aug 2026 — REGISTERED-PRINCIPAL REGISTER
- 06 Aug 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 06 Aug 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 03 Aug 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 29 Oct 2025 — USE AMENDMENT FILED
- 01 May 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 30 Apr 2026 — SOU EXTENSION 2 GRANTED
- 30 Oct 2025 — SOU EXTENSION 2 FILED
- 27 Apr 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 31 Oct 2025 — SOU TEAS EXTENSION RECEIVED
- 29 Oct 2025 — TEAS STATEMENT OF USE RECEIVED
- 24 May 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 23 May 2025 — SOU EXTENSION 1 GRANTED
- 23 May 2025 — SOU EXTENSION 1 FILED